You are here

melanoma

Bristol to seek melanoma approval for Opdivo ahead of expectations

Yahoo/Reuters

Thu, 07/10/14 - 10:20 am

Bristol-Myers Squibb

Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early

Yahoo/Fly on the Wall

Tue, 06/24/14 - 05:15 pm

Bristol-Myers Squibb

Bristol-Myers Squibb's Oncology Opportunity

Motley Fool

Tue, 06/24/14 - 09:11 am

Bristol-Myers Squibb

MELA Sciences initiates study on clinical impact of MelaFind on melanoma biopsy

Yahoo/Fly on the Wall

Tue, 06/3/14 - 11:42 am

Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14

TheStreet.com

Mon, 06/2/14 - 06:09 pm

Bristol Defends Data; Roche Shines In Cancer Showdown

Investors.com

Mon, 06/2/14 - 02:51 pm

Bristol-Myers Squibb

Merck Immunotherapy Posts Striking Results Against Advanced Melanoma

TheStreet.com

Mon, 06/2/14 - 10:42 am

Even If Provectus Successfully Markets PV-10 For Melanoma, It's Worth A Fraction Of The Current Stock Price

Seeking Alpha

Tue, 05/27/14 - 09:18 am

Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360

The Fly on the Wall

Tue, 05/27/14 - 09:14 am

Bristol-Myers Squibb

non-small cell lung cancer

colorectal cancer

Provectus Biopharmaceuticals Inc. Reaffirms Its Commitment to Bringing PV-10 to Market Notwithstanding FDA Decision on Breakthrough Therapy Designation

Yahoo/BusinessWire

Sat, 05/24/14 - 09:54 am

New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala

Seeking Alpha

Wed, 04/30/14 - 12:50 pm

Bristol-Myers Squibb

EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar

Yahoo/Reuters

Fri, 04/25/14 - 11:02 am

NeoStem Announces Definitive Agreement to Acquire California Stem Cell, Inc.

Yahoo

Mon, 04/14/14 - 08:46 am

California Stem Cell

Pfizer: It Never Rains, It Pours

Seeking Alpha

Wed, 04/9/14 - 08:55 am

Study Suggests Link Between Viagra And Melanoma

Forbes

Tue, 04/8/14 - 05:13 pm

erectile dysfunction

Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response Rate Met in Phase 3 Study of Talimogene, Secondary Endpoint Not Met

Yahoo/Benzinga

Fri, 04/4/14 - 09:14 am

Talimogene Laherparepvec

GSK melanoma drug combination faces delay in Europe

Yahoo/Reuters

Wed, 03/26/14 - 08:01 am

Who's going to win pharma's immunotherapy gold rush?

Fierce Biotech

Tue, 03/25/14 - 08:08 am

Bristol-Myers Squibb

anti-PD-1 immunotherapy

Bristol-Myers, Roche, working on possible blockbusters for melanoma, WSJ says

Yahoo/Fly on the Wall

Mon, 03/24/14 - 08:50 am

Bristol-Myers Squibb

Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study

Yahoo/The Fly on the Wall

Sat, 03/15/14 - 10:03 am

Talimogene Laherparepvec

Pages